<SEC-DOCUMENT>0001641172-25-012250.txt : 20250523
<SEC-HEADER>0001641172-25-012250.hdr.sgml : 20250523
<ACCEPTANCE-DATETIME>20250523170325
ACCESSION NUMBER:		0001641172-25-012250
CONFORMED SUBMISSION TYPE:	DEF 14C
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250523
FILED AS OF DATE:		20250523
DATE AS OF CHANGE:		20250523

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14C
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		25983278

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14C
<SEQUENCE>1
<FILENAME>formdef14c.htm
<DESCRIPTION>DEF 14C
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SCHEDULE
14C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
STATEMENT PURSUANT TO SECTION 14(C)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Information Statement</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential,
    for Use of the Commission Only (as permitted by Rule 14c-5(d)(2))</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Information Statement</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>CYCLACEL
PHARMACEUTICALS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check the appropriate box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item 25(b) of Schedule 14A (17 CFR 240.14a-101) per Item 1 of this Schedule and Exchange
    Act Rules 14c-5(g) and 0-11.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdef14c_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cyclacel
Pharmaceuticals, Inc.<BR>
Level 10, Tower 11, Avenue 5, No. 8</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jalan
Kerinchi, 59200 Kuala Lumpur, Malaysia</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF ACTION TAKEN BY WRITTEN CONSENT OF THE HOLDERS OF A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MAJORITY
OF THE VOTING POWER OF OUR CAPITAL STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
Our Stockholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
information statement (the &ldquo;Information Statement&rdquo;) is first being furnished by Cyclacel Pharmaceuticals, Inc., a Delaware
corporation (the &ldquo;Company&rdquo;, &ldquo;we&rdquo;, &ldquo;us&rdquo;, &ldquo;our&rdquo;, or &ldquo;Cyclacel&rdquo;) on or about
May 23, 2025 to the holders of record of the outstanding common stock of the Company, $0.001 par value per share (the &ldquo;Common Stock&rdquo;),
pursuant to Rule 14c-2 promulgated under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). This Information
Statement relates to actions taken by written consent in lieu of a meeting, on May 12, 2025 (the &ldquo;Written Consent&rdquo;) by the
stockholder owning a majority of shares of Common Stock issued and outstanding (the &ldquo;Majority Consenting Stockholder&rdquo;) of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Written Consent constitutes the consent of the Majority Consenting Stockholder and is sufficient under the General Corporation Law of
the State of Delaware and our bylaws, as amended (the &ldquo;Bylaws&rdquo;) to approve the actions described herein. Accordingly, they
are not presently being submitted to our other stockholders for a vote. Pursuant to Rule 14c-2 under the Exchange Act, the actions described
herein will not be implemented until a date at least 20 days after the date on which this Information Statement has been first mailed
to the stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Written Consent authorized the Company&rsquo;s board of directors (the &ldquo;Board&rdquo;) to amend the Company&rsquo;s amended and
restated certificate of incorporation, as amended (the &ldquo;Certificate of Incorporation&rdquo;) to effect a reverse stock split of
all outstanding shares of Common Stock, by a ratio that will not be less than one-for-three (1:3) or exceed a ratio of one-for-hundred
(1:100) (the &ldquo;Approved Split Ratios&rdquo;), to be determined in the Board&rsquo;s sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in this Information Statement, the foregoing actions were approved by the Majority Consenting Stockholder by Written Consent
and subsequently approved unanimously by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost of furnishing this Information Statement will be borne by the Company. The Company may request brokerage houses, nominees, custodians,
fiduciaries and other like parties to forward this Information Statement to the beneficial owners of Common Stock held of record by them
and will reimburse such persons for their reasonable charges and expenses in connection therewith. This Information Statement will be
first distributed to you on or about May 23, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
note that the number of votes already received from the Majority Consenting Stockholder is sufficient to satisfy the stockholder vote
requirement for this action under Delaware law and our certificate of incorporation, as amended, and consequently no additional votes
will be needed to approve the actions.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
NOTE THAT THIS IS <U>NOT</U> A NOTICE OF A MEETING OF STOCKHOLDERS AND NO STOCKHOLDERS MEETING WILL BE HELD TO CONSIDER THE MATTERS DESCRIBED
HEREIN. THIS INFORMATION STATEMENT IS BEING FURNISHED TO YOU SOLELY FOR THE PURPOSE OF INFORMING STOCKHOLDERS OF THE MATTERS DESCRIBED
HEREIN PURSUANT TO SECTION 14(C) OF THE EXCHANGE ACT AND THE REGULATIONS PROMULGATED THEREUNDER, INCLUDING REGULATION 14C.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
action is required by you. The accompanying Information Statement is being furnished only to inform our stockholders of the action taken
by written consent described above before the Reverse Stock Split and the Reverse Stock Split Amendment take effect in accordance with
Rule 14c-2, promulgated under the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Information Statement is being mailed to you on or about May 23, 2025. The effective date of the Information Statement will be no earlier
than June 12, 2025, or thereafter as our board of directors determines to effect it in accordance with applicable law, including the
General Corporation Law of the State of Delaware (&ldquo;DGCL&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    23, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Datuk Dr. Doris Wong Sing Ee</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong Sing Ee</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Executive Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdef14c_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cyclacel
Pharmaceuticals, Inc.<BR>
Level 10, Tower 11, Avenue 5, No. 8</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jalan
Kerinchi, 59200 Kuala Lumpur, Malaysia</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
STATEMENT PURSUANT TO SECTION 14(c) OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
EXCHANGE ACT OF 1934 AND REGULATION 14C THEREUNDER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Information Statement is being sent by mail to all record and beneficial owners of the common stock, $0.001 par value, and Preferred
Stock, $0.001 of Cyclacel Pharmaceuticals, Inc., a Delaware corporation, which we refer to herein as &ldquo;Cyclacel,&rdquo; &ldquo;the
Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; or &ldquo;us.&rdquo; The mailing date of this Information Statement is on or about
May 23, 2025. The Information Statement has been filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) and is being
furnished, pursuant to Regulation 14C of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), to notify
our stockholders of actions we are taking pursuant to a written consent executed by stockholders representing a majority of the voting
power of our capital stock in lieu of a meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 12, 2025, the record date for determining the identity of stockholders who are entitled to receive this Information Statement, we
had issued and outstanding (i) 22,272,346 shares of common stock, (ii) 135,273 shares of our 6% Convertible Exchangeable Preferred
Stock, par value $0.001 per share, and (iii) 264 shares of our Series A Convertible Preferred Stock, par value $0.001 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
our shares of common stock are Cyclacel voting securities. Each share of common stock entitles the holder thereof to one vote on all
matters submitted to stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
vote or other consent of our stockholders is solicited in connection with this information statement. We are not asking you for a proxy
and you are requested not to send us a proxy.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has approved to amend the Company&rsquo;s certificate of incorporation, as amended (the &ldquo;Certificate
of Incorporation&rdquo;) to effect a reverse stock split of all issued and outstanding shares of Common Stock, by a ratio that
will not be less than a ratio of one-for-three (1:3) or exceed a ratio of one-for-hundred (1:100) (the &ldquo;Approved Split Ratios&rdquo;),
to be determined in the Board&rsquo;s sole discretion (the &ldquo;Reverse Stock Split&rdquo;). No other corporate actions to be taken
by written consent were considered. The form of the proposed amendment to the Certificate of Incorporation (the &ldquo;Reverse Stock
Split Amendment&rdquo;) is attached to this proxy statement as <U>Appendix A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 12, 2025, a stockholder who beneficially holds 12,164,301 shares of common stock (the &ldquo;Majority Consenting Stockholder&rdquo;)
representing approximately 54.6% of the voting power of our outstanding voting securities as of May 12, 2025 (the &ldquo;Record Date&rdquo;),
executed and delivered to the board of directors a written consent approving the Reverse Stock Split and the Reverse Stock Split Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
the action was approved by the written consent of the Majority Consenting Stockholder holding a majority of our outstanding voting securities,
no proxies are being solicited with this Information Statement. We are not aware of any substantial interest, direct or indirect, by
security holders or otherwise, that is in opposition to matters of action being taken. In addition, pursuant to the laws of the State
of Delaware, the action to be taken by majority written consent in lieu of a special stockholder meeting does not create appraisal or
dissenters&rsquo; rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board believes that the stockholders of the Company will benefit from the Reverse Stock Split because it believes that such Reverse
Stock Split could be a catalyst for an increase in the stock price of the Common Stock, which in turn could increase the marketability
and liquidity of the Company&rsquo;s Common Stock, as well as increase the profile of the Company for private investment, acquisitions
and other future opportunities that become available to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
it is the Board&rsquo;s opinion that the Reverse Stock Split and the Reverse Stock Split Amendment, would better position the Company
to attract potential business candidates and provide the stockholders a greater potential return.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors determined to pursue stockholder action by majority written consent of those shares entitled to vote in an effort
to reduce the costs and management time required to hold a special meeting of stockholders and to implement the above action in a timely
manner. Under Section 14(c) of the Exchange Act, actions taken by written consent without a meeting of stockholders cannot become effective
until at least 20 days after the mailing date of this definitive Information Statement. We are not seeking written consent from any stockholders
other than as set forth above and our other stockholders will not be given an opportunity to vote with respect to the actions taken.
All necessary corporate approvals have been obtained, and this Information Statement is furnished solely for the purpose of advising
stockholders of the actions taken by written consent and giving stockholders advance notice of the actions taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORWARD-LOOKING
INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Information Statement and other reports that we file with the SEC contain certain forward-looking statements relating to future events.
In some cases, you can identify forward-looking statements by terminology such as &ldquo;may,&rdquo; &ldquo;will&rdquo; &ldquo;should,&rdquo;
&ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;predict,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo; or similar terms, variations of such terms or the negative of
such terms. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including those
risks discussed elsewhere herein. Although forward-looking statements, and any assumptions upon which they are based, are made in good
faith and reflect our current judgment, actual results could differ materially from those anticipated in such statements. Except as required
by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements
to conform these statements to actual results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OUTSTANDING
VOTING SECURITIES AND CONSENTING STOCKHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 12, 2025, the Majority Consenting Stockholder who beneficially owned 12,164,301 shares of common stock (representing approximately
54.6% of the total voting power) executed and delivered to the board of directors a written consent approving (i) the Reverse Stock Split
and (ii) the Reverse Stock Split Amendment, a form of which is attached hereto as <U>Appendix A</U>. Because the actions were approved
by a stockholder who owns a majority of our outstanding voting power, no proxies are being solicited with this Information Statement.
No consideration was paid for the consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of the consent by the Majority Consenting Stockholder, Cyclacel had issued and outstanding approximately 22,272,346 shares
of common stock, which represent the voting securities of Cyclacel. Each share of common stock entitles the holder thereof to one vote
on all matters submitted to stockholders. All shares of our common stock have equal rights and privileges with respect to voting, liquidation
and dividend rights. Each share entitles the holder thereof to (i) one non-cumulative vote for each share held of record on all matters
submitted to a vote of the stockholders; (ii) to participate equally and to receive any and all such dividends as may be declared by
the board of directors; and (iii) to participate pro rata in any distribution of assets available for distribution upon liquidation after
the payment of all debts and other liabilities. Holders of our common stock have no preemptive rights to acquire additional shares of
common stock or any other securities. The common stock is not subject to redemption and carries no subscription or conversion rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
General Corporation Law of the State of Delaware (&ldquo;DGCL&rdquo;) provides in substance that unless a company&rsquo;s certificate
of incorporation provides otherwise, stockholders may take any action without a meeting of stockholders, without prior notice and without
a vote if a consent or consents in writing, setting forth the action so taken, is signed by holders of the outstanding stock having not
less than the minimum number of votes that would be necessary to authorize and take such action at a meeting at which all shares entitled
to vote thereon were present voted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors and the Majority Consenting Stockholder have therefore approved (i) the Reverse Stock Split and (ii) the Reverse Stock
Split Amendment, a form of which is attached hereto as <U>Appendix A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
20 days after the furnishing of this Information Statement to stockholders, our board of directors will have the authority, in its sole
discretion, without further action by our stockholders, to effect the Reverse Stock Split and the Reverse Stock Split Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REVERSE
SPLIT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 12, 2025, the Company&rsquo;s Board of directors unanimously approved the Reverse Stock Split of the issued and outstanding
shares of Common Stock, including shares of Common Stock reserved for issuance, at a ratio of any whole number within the Approved Split
Ratios, with such ratio, time and date to be determined by the Company&rsquo;s Board of directors and the Reverse Stock Split
Amendment (collectively, the &ldquo;Corporate Action&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporate Action, which provides for the implementation of the Reverse Stock Split, was based upon and approved by the Majority Consenting
Stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Material
Terms of the Reverse Stock Split</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 12, 2025, the Record Date, the Company has 22,272,346 issued and outstanding shares of Common Stock, which does not include shares
of Common Stock reserved for issuance underlying certain derivative securities. The Majority Consenting Stockholder owns, in the aggregate,
approximately 54.6% of the total voting power of all issued and outstanding voting shares of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Stock Split will become effective at the time specified in the Reverse Stock Split Amendment, if and when filed with
the Secretary of State of the State of Delaware. The exact ratio of the Reverse Stock Split, within the Approved Split Ratios, will
not be less than a ratio of one-for-three (1:3) or exceed a ratio of one-for-hundred (1:100) range, would be determined by the Board
in its sole discretion, and publicly announced by the Company prior to filing the Reverse Stock Split Amendment. In determining the
appropriate ratio for the Reverse Stock Split, our Board will consider, among other things, factors such as:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            minimum price per share requirements of The Nasdaq Capital Market;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            historical trading price and trading volume of our Common Stock;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of shares of our Common Stock outstanding and anticipated equity financing transactions
                                            in the future;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            then-prevailing trading price and trading volume of our Common Stock and the anticipated
                                            impact of the Reverse Stock Split on the trading market for our Common Stock;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">business
                                            developments affecting us; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prevailing
                                            general market and economic conditions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> believes that the Reverse Stock
Split and the Reverse Stock Split Amendment, will affect all holders of shares of Common Stock and holders of derivative securities equally.
The Company believes that if implemented, the Reverse Stock Split and the Reverse Stock Split Amendment, will benefit all stockholders,
as without the Reverse Stock Split and the Reverse Stock Split Amendment, the Company may have difficulties maintaining compliance
with the listing requirements of Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
the reduction in the number of issued and outstanding shares of Common Stock following implementation of the Reverse Stock Split and
the Reverse Stock Split Amendment, if implemented, could adversely affect the trading market for our Common Stock by reducing the relative
level of liquidity of the shares of Common Stock. Further, there can be no assurance that the Reverse Stock Split will result in a proportionate
increase or, for that matter, any increase in the price of the shares of Common Stock on Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
new shares issued following the effective date (the &ldquo;Effective Date&rdquo;) of the Reverse Stock Split will be fully-paid and non-assessable
shares. On the Effective Date of the Reverse Stock Split, the number of stockholders will remain unchanged because those stockholders
who would otherwise only be entitled to receive a fractional share will receive a number of shares rounded up to the next whole number.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Stock Split and the Reverse Stock Split Amendment will not change the number of authorized shares of Common Stock, which will
continue to be six hundred million (600,000,000) shares of Common Stock, or the par value of our Common Stock, which will continue to
be $0.001 per share. While the aggregate par value of our outstanding Common Stock will be reduced as a result of the Reverse Stock Split
and the Reverse Stock Split Amendment, our additional paid-in capital will be increased by a corresponding amount. Therefore, the Reverse
Stock Split will not affect our total stockholders&rsquo; equity. All share and per share information will be retroactively adjusted
to reflect the Reverse Stock Split for all periods presented in our future financial reports and regulatory filings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 22, 2025, the trading date immediately preceding the filing of the Definitive Information Statement on Schedule 14C, the closing
price of our shares on Nasdaq was $1.45 and the total market value was approximately $34,451,238.75 based on approximately
23,759,475 issued and outstanding shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Rationale
for the Reverse Stock Split and the Reverse Stock Split Amendment</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board authorized the Reverse Stock Split of our Common Stock and the Reverse Stock Split Amendment, in the event we may be required
to increase the price of our Common Stock in order to meet the price criteria for continued listing on Nasdaq. Our Common Stock is
publicly traded and listed on Nasdaq under the symbol &ldquo;CYCC.&rdquo; Our Board believes that, in addition to increasing the price
of our Common Stock, the Reverse Stock Split would make our Common Stock more attractive to a broader range of institutional and other
investors. Accordingly, for these and other reasons discussed below, we believe that if implemented, the Reverse Stock Split would
be in the Company&rsquo;s and our stockholders&rsquo; best interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
stockholders should understand that as of the date of the Definitive Information Statement, our Board has not determined whether it
will implement a Reverse Stock Split, the exact ratio of the Reverse Stock Split among the Approved Split Ratios or the date that
the Reverse Stock Split may be implemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of directors</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> believes that the Reverse Stock
Split will affect all holders of shares of Common Stock and holders of derivative securities equally. The Company believes that the Reverse
Stock Split if implemented, will benefit all stockholders, as without the Reverse Stock Split, the Company may  have
difficulties maintaining compliance with the listing requirements of Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Reverse Stock Split and the Reverse Stock Split Amendment, will not increase the total market value of our Common Stock, our Board
of directors believes that the increase in the price of our shares of Common Stock, which increase may not necessarily be sustained,
should make our shares of Common Stock more attractive to potential investors, encourage investor interest and trading in, and possibly
the marketability of, our Common Stock, and allow us to maintain compliance with Nasdaq&rsquo;s $1.00 minimum bid price requirement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, because brokers&rsquo; commissions on lower-priced stocks generally represent a higher percentage of the stock price than commissions
on higher-priced stocks, the current per share price of our Common Stock can result in individual stockholders paying transaction costs
(commissions, markups, or markdowns) that constitute a higher percentage of their total share value than would be the case if the share
price of our Common Stock was higher. This difference in transaction costs may also limit the willingness of institutional investors
to purchase shares of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
in our shares of Common Stock also may be adversely affected by a variety of policies and practices of brokerage firms that discourage
individual brokers within those firms from dealing in low-priced stocks. These policies and practices pertain to the payment of brokers&rsquo;
commissions and to time-consuming procedures that make the handling of low-priced stocks unattractive to brokers from an economic standpoint.
Similarly, many brokerage firms are reluctant to recommend low-priced stocks to their customers and the analysts at many brokerage firms
do not provide coverage for such stocks. The Board also believes that the decrease in the number of shares of Common Stock outstanding
as a consequence of the Reverse Stock Split and the Reverse Stock Split Amendment, and the anticipated increase in the price of the Common
Stock, could generate interest in the Common Stock and possibly promote greater liquidity for the Company&rsquo;s stockholders. However,
the Company&rsquo;s aggregate market capitalization could be reduced to the extent that any increase in the market price of the Common
Stock resulting from the Reverse Stock Split and the Reverse Stock Split Amendment is proportionately less than the decrease in the number
of shares of Common Stock outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
ultimately cannot predict whether, and to what extent, the Reverse Stock Split would achieve the desired results. The price per share
of our Common Stock is a function of various factors, including the profitability of our business operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
there can be no assurance that the market price of our Common Stock after the Reverse Stock Split and the Reverse Stock Split Amendment
would increase in an amount proportionate to the decrease in the number of issued and outstanding shares, or would increase at all, that
any increase can be sustained for a prolonged period of time or that the Reverse Stock Split and the Reverse Stock Split Amendment, would
enhance the liquidity of, or investor interest in, our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, our board of directors believes that the potential positive effects of the Reverse Stock Split may outweigh
the potential disadvantages. In making this determination, our Board of directors will take into account various negative
factors, including: (i) the negative perception of Reverse Stock Splits held by some stock market participants; (ii) the adverse effect
on liquidity that might be caused by a reduced number of shares outstanding; and (iii) the costs associated with implementing the Reverse
Stock Split. The effect of the Reverse Stock Split upon the market price of our Common Stock cannot be predicted with any certainty,
and the history of similar stock splits for companies in similar circumstances to ours is varied. It is also possible that the Reverse
Stock Split may not increase the per share price of our Common stock in proportion to the reduction in the number of shares of our Common
Stock outstanding or result in a permanent increase in the per share price, which depends on many factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors will consider</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> the foregoing factors,
in determining whether to implement the Reverse Stock Split in our best interests and that of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>Reservation of Right to Abandon the Proposed
Reverse Split Amendment to our Certificate</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our board of directors
reserves the right not to file the Reverse Split Amendment to our Certificate without further action by our stockholders at any time
before the effectiveness of the filing of the Reverse Stock Split Amendment with the Secretary of State of the State of Delaware, even
with the authority to effect the Reverse Stock Split Amendment as approved by the Majority Consenting Stockholder. Our board of directors
is authorized to delay, not proceed with, and abandon, the proposed Reverse Stock Split Amendment if it should so decide, in its sole
discretion, that such action is in the best interests of the Company and its stockholders.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Effects
of the Reverse Stock Split and the Reverse Stock Split Amendment</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the filing of the Definitive Information Statement on Schedule 14C and in the event of the final determination by our Board
of directors of the ratio of the Reverse Stock Split among the Approved Split Ratios, which is expected to be any whole number in
the range of will not be less than a ratio of one-for-three (1:3) or exceed a ratio of one-for-hundred (1:100), the Company will file
a Certificate of Amendment to our Certificate of Incorporation with the State of Delaware substantially in the form of <U>Exhibit A</U>
to this Information Statement and submit a Corporate Event Notification Form to Nasdaq and take the appropriate actions in order to comply
with Nasdaq Rule 5250(e)(7).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the number of shares of Common Stock issued and outstanding, the rights and preferences of shares of our Common Stock prior and subsequent
to the Reverse Stock Split and the Reverse Stock Split Amendment would remain the same. We do not anticipate that our financial condition,
the percentage of our stock owned by management, the number of our stockholders, or any aspect of our current business would materially
change as a result of the Reverse Stock Split and the Reverse Stock Split Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is currently registered under Section 12(b) of the Exchange Act and, as a result, we are subject to periodic reporting and
other requirements. The proposed Reverse Stock Split would not affect the registration of our Common Stock under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Effective Date of the Reverse Stock Split, each stockholder would own a reduced number of shares of our Common Stock, based upon
the final ratio determined by our board of directors among the Approved Split Ratios. However, a Reverse Stock Split would affect
all stockholders equally and will not affect any stockholder&rsquo;s percentage ownership of the Company, except for the immaterial result
that the Reverse Stock Split may involve in the rounding up or down of any fractional shares to the next whole in such
a manner as described in the Reverse Stock Split Amendment. Proportionate voting rights and other rights and preferences of the
holders of our Common Stock would not be affected by the Reverse Stock Split. There will be no payment of cash in lieu of any fractional
shares. Furthermore, the number of stockholders of record would not be affected by the Reverse Stock Split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Authorized
but Unissued Shares; Potential Dilution and Anti-Takeover Effects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the Effective Date of the Reverse Stock Split and the Reverse Stock Split Amendment, the Company will continue to have 600,000,000 shares
of Common Stock authorized. The ultimate determination of our board of directors on the ratio of the Reverse Stock Split shall
be based upon, among other factors, the prevailing market price of the Company&rsquo;s shares of Common Stock during the period prior
to the Reverse Stock Split determination. After the Reverse Stock Split is implemented, there will be available, in any event, a significant
number of authorized but unissued shares of Common Stock available for issuance from time to time for business purposes as reasonably
determined by our board of directors, including for use in capital-raising transactions and acquisitions, among other purposes,
consistent with our business objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant increase in the proportion of unissued authorized shares to issued shares after the Reverse Stock Split could, under certain
circumstances, have an anti-takeover effect (for example, by permitting issuances that would dilute the stock ownership of a person seeking
to effect a change in the composition of our board of directors or contemplating a tender offer or other transaction for the combination
of our Company with another company), we are not proposing the Reverse Stock Split and the Reverse Stock Split Amendment in response
to any effort of which we are aware to accumulate any of our shares of our Common Stock or to otherwise seek to obtain control of the
Company. Our board of directors does not currently contemplate recommending the adoption of any other proposals that could be
construed to affect the ability of anyone to take over or change the control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the availability of the additional shares will provide us with the flexibility to pursue potential transactions as they
arise, to take advantage of desirable business opportunities and to respond effectively in a changing corporate environment. For example,
we may elect to issue shares of Common Stock to raise equity capital, to make acquisitions using shares of Common Stock, to establish
strategic relationships with other companies, to adopt additional employee benefit plans or reserve additional shares for issuance under
such plans, where the Board determines it advisable to do so, without the necessity of soliciting further stockholder approval, subject
to applicable stockholder vote requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we issue additional shares for any of the above purposes, the aggregate ownership interest of our current stockholders, and the interest
of each such existing stockholder, would be diluted, possibly substantially. Furthermore, the additional shares of Common Stock that
would become available for issuance upon the Effective Date of the Reverse Stock Split and the Reverse Stock Split Amendment could also
be used by the Company&rsquo;s management to oppose any potential hostile takeover attempt or delay or prevent changes in control or
changes in or removal of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
example, without further stockholder approval, our board of directors could authorize the issuance and sale of shares of Common
Stock in one or more private transactions to purchasers who would oppose a takeover or favor the current Board. Although the Reverse
Stock Split and the Reverse Stock Split Amendment was based upon business and financial considerations that we consider reasonable and
necessary as of the Record Date, as discussed above, stockholders nevertheless should be aware that approval of one or more of the proposals
could facilitate future efforts by management to deter or prevent a change in control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fairness
of the Process</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> did not obtain a report, opinion
or appraisal from an appraiser or financial advisor with respect to the Reverse Stock Split and no representative or advisor was retained
on behalf of the unaffiliated stockholders to review or negotiate the transaction. Our board of directors concluded that the additional
expense of these independent appraisal procedures was unreasonable in relation to the Company&rsquo;s available cash resources and concluded
that our board of directors could adequately establish the fairness of the Reverse Stock Split without the engagement of third
parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin: 0pt 0 0pt 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>No Appraisal Rights</I></B></P>

<P STYLE="margin: 0pt 0 0pt 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.25in">No appraisal
rights are available under the General Corporation Law of the State of Delaware or under our Certificate, or our Amended and Restated
Bylaws, as amended, with respect to the Reverse Stock Split. There may exist other rights or actions under state law for stockholders
who are aggrieved by reverse stock splits generally.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Material
U.S. Federal Income Tax Consequences</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of material U.S. federal income tax consequences of a Reverse Stock Split to stockholders. This summary is based
on the provisions of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), U.S. Treasury regulations, administrative
rulings and judicial decisions, all as in effect on the date of this filing, and all of which are subject to change or differing interpretations,
possibly with retroactive effect. Any such change or differing interpretation could affect the tax consequences described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not sought and will not seek an opinion of counsel or ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;) with respect
to the statements made and the conclusions reached in the following summary, and there can be no assurance that the IRS or a court will
agree with such statements and conclusions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is limited to stockholders that are U.S. holders, as defined below, and that hold our common stock as a capital asset (generally,
property held for investment).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is for general information only and does not address all U.S. federal income tax considerations that may be applicable to a holder&rsquo;s
particular circumstances or to holders that may be subject to special tax rules, such as, for example, brokers and dealers in securities,
currencies or commodities, banks and financial institutions, regulated investment companies, real estate investment trusts, expatriates,
tax-exempt entities, governmental organizations, traders in securities that elect to use a mark-to-market method of accounting for their
securities, certain former citizens or long-term residents of the U.S., insurance companies, persons holding shares of our common stock
as part of a hedging, integrated or conversion transaction or a straddle or persons deemed to sell shares of our common stock under the
constructive sale provisions of the Code, persons that hold more than 5% of our common stock, persons that hold our common stock in an
individual retirement account, 401(k) plan or similar tax-favored account or partnerships or other pass-through entities for U.S. federal
income tax purposes and investors in such entities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary does not address any U.S. federal tax consequences other than U.S. federal income tax consequences (such as estate or gift tax
consequences), the Medicare tax on net investment income, the alternative minimum tax or any U.S. state, local or foreign tax consequences.
This summary also does not address any U.S. federal income tax considerations relating to any other transaction other than the Reverse
Stock Split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this summary, a &ldquo;U.S. holder&rdquo; means a beneficial owner of our common stock that is, for U.S. federal income tax
purposes:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual who is a citizen or resident of the U.S.;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation created or organized in or under the laws of the U.S., any state thereof or the District of Columbia;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate the income of which is subject to U.S. federal income taxation regardless of its source; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust if (1) it is subject to the primary supervision of a court within the U.S. and one or more U.S. persons have the authority
    to control all substantial decisions of the trust or (2) it has a valid election in effect under applicable U.S. Treasury regulations
    to be treated as a U.S. person.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an entity (or arrangement) classified as a partnership for U.S. federal income tax purposes holds shares of our common stock, the tax
treatment of a partner in the partnership will generally depend upon the status of the partner and the activities of the partnership.
If a holder of our common stock is a partner of a partnership holding shares of our common stock, such holder should consult his or her
own tax advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary of certain U.S. federal income tax consequences is for general information only and is not tax advice. Stockholders are urged
to consult their own tax advisor with respect to the application of U.S. federal income tax laws to their particular situation as well
as any tax considerations arising under other U.S. federal tax laws (such as the estate or gift tax laws) or under the laws of any state,
local, foreign or other taxing jurisdiction or under any applicable tax treaty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Stock Split is intended to be treated as a recapitalization for U.S. federal income tax purposes. Assuming the Reverse Stock
Split qualifies as a recapitalization, except as described below with respect to cash received in lieu of a fractional share, a U.S.
holder will not recognize any gain or loss for U.S. federal income tax purposes upon the Reverse Stock Split. In the aggregate, a U.S.
holder&rsquo;s tax basis in the common stock received pursuant to the Reverse Stock Split (excluding the portion of the tax basis that
is allocable to any fractional share) will equal the U.S. holder&rsquo;s tax basis in its common stock surrendered in the Reverse Stock
Split in exchange therefor, and the holding period of the U.S. holder&rsquo;s common stock received pursuant to the Reverse Stock Split
will include the holding period of the common stock surrendered in the Reverse Stock Split in exchange therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a U.S. holder who receives a cash payment in lieu of a fractional share will recognize capital gain or loss equal to the difference
between the amount of cash received in lieu of the fractional share and the portion of the U.S. holder&rsquo;s tax basis of the common
stock surrendered in the Reverse Stock Split that is allocable to the fractional share. Such gain or loss generally will be long-term
capital gain or loss if the U.S. holder&rsquo;s holding period in its common stock surrendered in the Reverse Stock Split is more than
one year as of the date of the Reverse Stock Split. The deductibility of net capital losses by individuals and corporations is subject
to limitations. Depending on a stockholder&rsquo;s individual facts and circumstances, it is possible that cash received in lieu of a
fractional share could be treated as a distribution under Section 301 of the Code, so stockholders should consult their own tax advisors
as to that possibility and the resulting tax consequences to them in that event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
holders that have acquired different blocks of our common stock at different times or at different prices are urged to consult their
own tax advisors regarding the allocation of their aggregated adjusted basis among, and the holding period of, our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
returns generally will be required to be filed with the IRS with respect to the payment of cash in lieu of a fractional share made pursuant
to the Reverse Stock Split unless such U.S. holder is an exempt recipient and timely and properly establishes with the applicable withholding
agent the exemption. In addition, payments of cash in lieu of a fractional share made pursuant to the Reverse Stock Split may, under
certain circumstances, be subject to backup withholding, unless a U.S. holder timely provides to the applicable withholding agent proof
of an applicable exemption or a correct taxpayer identification number, and otherwise complies with the applicable requirements of the
backup withholding rules. Any amounts withheld under the backup withholding rules are not additional tax and may be refunded or credited
against the U.S. holder&rsquo;s U.S. federal income tax liability, provided that the U.S. holder timely furnishes the required information
to the IRS. U.S. holders should consult their tax advisors regarding their qualification for an exemption from backup withholding and
the procedures for obtaining such an exemption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Street
Name Holders of Common Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends for the Reverse Stock Split to treat stockholders holding Common Stock in street name through a nominee (such as a bank
or broker) in the same manner as stockholders whose shares are registered in their names. Nominees will be instructed to affect the Reverse
Stock Split for their beneficial holders. However, nominees may have different procedures. Accordingly, stockholders holding Common Stock
in street name should contact their nominees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Certificates</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mandatory
surrender of certificates is not required by our stockholders. The Company&rsquo;s transfer agent will adjust the record books of the
company to reflect the Reverse Stock Split as of the Effective Date of the Reverse Stock Split. New certificates will not be mailed to
stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTEREST
OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
Dr. Doris Wong, the Company&rsquo;s Chief Executive Officer and a current member of our Board is the sole Majority Consenting Stockholder.
As of the Record Date, the Majority Consenting Stockholder held 12,164,301 shares of our Common Stock, or approximately 54.6% of the
Company&rsquo;s outstanding Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our other directors, executive officers or any associate of a director or executive officer has a substantial interest, direct or
indirect, by security holdings or otherwise, in any matter described in this Information Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the beneficial ownership of Cyclacel common stock and preferred stock as of May 23, 2025 by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person, or group of affiliated persons, who we know to beneficially own more than 5% of Cyclacel common stock;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our named executive officers;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our current directors; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    of our current executive officers and directors as a group.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
percentage ownership information shown in the table is based on an aggregate of 23,759,475 shares of our common stock and the
percentage of ownership of preferred stock is based on 135,537 shares of preferred stock outstanding as of May 22, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities.
We deem shares of Common Stock that may be acquired by an individual or group within 60 days of May 23, 2025 pursuant to the exercise
of options or warrants to be outstanding for the purpose of computing the percentage ownership of an individual or group but do not deem
them to be outstanding for the purpose of computing the percentage ownership of any other person shown in the table. Except as indicated
in footnotes to this table, we believe that the stockholders named in this table have sole voting and investment power with respect to
all shares of stock shown to be beneficially owned by them based on information provided to us by these stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name of Beneficial Owners<SUP>(1)</SUP></B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Shares of Common Stock Beneficially Owned</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock<SUP>(2)</SUP></B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of Shares of Preferred Stock Beneficially Owned <SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage of Preferred Stock Owned <SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">David Lazar</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">2,438,824</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">10.24</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Armistice Capital Master Fund Ltd.<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,552,795</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 6.54 </TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ho Kee Wee<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,718,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 7.23 </TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tan Kok Hui<SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,718,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 7.23 </TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suria Sukses Engineering Sdn. Bhd.<SUP>(6)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,718,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 7.23 </TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ho Jien Shiung<SUP>(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,718,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 7.23 </TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk Dr. Doris Wong Sing Ee<SUP>(8)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,164,301</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 51.2 </TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Kiu Cu Seng</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Kwang Fock Chong</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Dr. Satis Waran Nair Krishnan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Inigo Angel Laurduraj</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">All current directors and executive officers as a group (5 people)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0"> 23,030,920 </P></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0"> 96.9 </P></TD><TD STYLE="text-align: left"> % </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> - </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Represents
                                            beneficial ownership of less than one percent of our outstanding shares of Common Stock.</FONT></TD></TR>
                                                                                                                                      <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                                                                      <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            otherwise indicated, the address of each beneficial owner is c/o Cyclacel Pharmaceuticals,
                                            Inc., Cyclacel Pharmaceuticals, Inc., Level 10, Tower 11, Avenue 5, No. 8 Jalan Kerinchi,
                                            59200 Kuala Lumpur, Malaysia.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
                                            the reverse stock split effective on May 12, 2025.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Armistice
                                            Capital Master Fund Ltd. (&ldquo;Armistice&rdquo;) and the Company entered into that certain
                                            Warrant Exchange Agreement dated January 2, 2025 (&ldquo;Warrant Exchange Agreement&rdquo;),
                                            pursuant to which they agreed to exchange certain Exchanged Warrants (as defined in the Warrant
                                            Exchange Agreement) previously acquired by Armistice for 24,844,725 shares of common stock
                                            and cash consideration. The address for Armistice is c/o Armistice Capital, LLC, 510 Madison
                                            Avenue, 7th Floor, New York, New York 10022. Armistice is a Cayman Islands exempted company
                                            operating as a hedge fund focused primarily on the health care and consumer sectors. We have
                                            been advised that Steven Boyd has the power to vote or direct the vote and power to dispose
                                            or to direct the disposition of all securities owned directly by Armistice. We have been
                                            advised that Armistice is a member of the Financial Industry Regulatory Authority (&ldquo;FINRA&rdquo;),
                                            or an independent broker-dealer, and that neither Armistice nor any of its affiliates is
                                            an affiliate or an associated person of any FINRA member or independent broker-dealer.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            solely on the Securities Purchase Agreement dated March 21, 2025 between the Company and
                                            Ho Kee Wee, as filed within the Company&rsquo;s Current Report on Form 8-K filed with the
                                            SEC on March 24, 2025 for the purchase of 250,000 shares of Series E Preferred Stock that
                                            were converted into 27,500,000 shares of common stock before the reverse stock split effective
                                            May 12, 2025.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            solely on the Securities Purchase Agreement dated March 21, 2025 between the Company and
                                            Tan Kok Hui, as filed within the Company&rsquo;s Current Report on Form 8-K filed with the
                                            SEC on March 24, 2025 for the purchase of 250,000 shares of Series E Preferred Stock that
                                            were converted into 27,500,000 shares of common stock before the reverse stock split effective
                                            May 12, 2025.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            solely on the Securities Purchase Agreement dated March 21, 2025 between the Company and
                                            Suria Sukses Engineering Sdn. Bhd. (&ldquo;Suria&rdquo;), as filed within the Company&rsquo;s
                                            Current Report on Form 8-K filed with the SEC on March 24, 2025 for the purchase of 250,000
                                            shares of Series E Preferred Stock that were converted into 27,500,000 shares of common stock
                                            before the reverse stock split effective May 12, 2025. The address for Suria is 26-13A Stellar
                                            Suites, Jalan Puteri 4/7, Bandar Puteri, 47100 Puchong, Selangor, Malaysia. Suria is in the
                                            business of production of the Giant HVLS fan in Malaysia sold under the brand Suria Giant
                                            Fan. We have been advised that Chen Choon Seng has power to vote or direct the vote and power
                                            to dispose or to direct the disposition of all securities owned directly by Suria.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            solely on the Securities Purchase Agreement dated March 21, 2025 between the Company and
                                            Ho Jien Shiung, as filed within the Company&rsquo;s Current Report on Form 8-K filed with
                                            the SEC on March 24, 2025 for the purchase of 250,000 shares of Series E Preferred Stock
                                            that were converted into 27,500,000 shares of common stock before the reverse stock split
                                            effective May 12, 2025.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company&rsquo;s Chief Executive Officer, Datuk Dr. Doris Wong Sing Ee is the Majority Stockholder
                                            referred to herein who controls the management and affairs of the Company, and currently
                                            can control matters requiring the approval by the Company&rsquo;s stockholders, including
                                            the election of directors, any merger, consolidation or sale of all or substantially all
                                            of its assets, and any other significant corporate transaction.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REASONS
WE USED STOCKHOLDER CONSENT AS OPPOSED TO SOLICITATION OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCKHOLDER
APPROVAL VIA PROXY STATEMENT AND SPECIAL MEETING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Reverse Stock Split requires stockholder approval. Stockholder approval could have been obtained by us in one of two ways: (i) by the
dissemination of a proxy statement and subsequent majority vote in favor of the actions at a stockholder meeting called for such purpose,
or (ii) by the written consent of the holders of a majority of our voting securities. However, the latter method, while it represents
the requisite stockholder approval, with regard to the Reverse Stock Split, is not deemed effective until twenty (20) days after this
Information Statement has been sent to all of our stockholders giving them notice and informing them of the actions approved by such
consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
that we have already secured the affirmative consent of the holder of a majority of our voting securities to the a Reverse Stock Split,
we determined that it would be a more efficient use of limited corporate resources to forego the dissemination of a proxy statement and
subsequent majority vote in favor of the actions at a stockholders meeting called for such a purpose, and rather proceed through the
written consent of the holder of a majority of our voting securities. Spending the additional company time, money and other resources
required by the proxy and meeting approach would have been potentially wasteful and, consequently, detrimental to completing these actions
in a manner that is timely and efficient for our Company and our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the information and periodic requirements of the Exchange Act and, in accordance therewith, file annual, quarterly and
current reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information
statements and other information regarding registrants that file electronically with the SEC. The address is www.sec.gov. We also maintain
a website at https://cyclacel.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may access our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports
filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act with the SEC free of charge as soon as reasonably practicable
after they are electronically filed with, or furnished to, the SEC. The reference to our website does not constitute incorporation by
reference of the information contained on or accessible through our website, and you should not consider the contents of our website
in making an investment decision with respect to our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EFFECTIVE
DATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Rule 14c-2 under the Exchange Act, the above action to effect the approval and the Authorized Shares Increase will not be effective
until a date at least 20 days after the date on which the definitive Information Statement has been mailed to the stockholders. Following
such date, our board of directors will have the authority, without further action by our stockholders, to effect the Reverse Stock Split
and the Reverse Stock Split Amendment, the form of which is attached hereto as <U>Appendix A</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
though the holders of a majority of the voting power of our capital stock have already approved the Reverse Stock Split and the Reverse
Stock Split Amendment, we reserve the right not to effect any increase in our number of authorized shares of common stock if our board
of directors does not deem it to be in the best interests of our stockholders. The Company believes that granting this discretion provides
our board of directors with maximum flexibility to act in the best interests of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HOUSEHOLDING
OF STOCKHOLDER MATERIALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
bank, brokerage firm or other nominee record holders may be participating in the practice of &ldquo;householding&rdquo; information statements.
This means that only one copy of this Information Statement may have been sent to multiple stockholders in your household. We will promptly
deliver a separate copy of the Information Statement to you if you contact us at: Cyclacel Pharmaceuticals, Inc., Level 10, Tower 11,
Avenue 5, No. 8 Jalan Kerinchi, 59200 Kuala Lumpur, Malaysia, Attn: Corporate Secretary. You may also contact us at (908) 517-7330.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you want to receive separate copies of the notice of Information Statement, or if you are receiving multiple copies and would like to
receive only one copy for your household, you should contact your bank, brokerage firm or other nominee record holder, or you may contact
us at the above address or phone number.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
entire cost of furnishing this Information Statement will be borne by the Company. We will request brokerage houses, nominees, custodians,
fiduciaries and other like parties to forward this Information Statement to the beneficial owners of the common stock held of record
by them and will reimburse such persons for their reasonable charges and expenses in connection therewith. The board of directors has
fixed the close of business on May 12, 2025, as the Record Date for the determination of stockholders who are entitled to receive this
Information Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Information Statement is being mailed on or about May 23, 2025 to all stockholders of record as of the record date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONCLUSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a matter of regulatory compliance, we are sending you this Information Statement that describes the purpose and effect of the above actions.
Your consent to the above action is not required and is not solicited in connection with this action. This Information Statement is intended
to provide our stockholders information required by the rules and regulations of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WE
ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY. THE ATTACHED MATERIAL IS FOR INFORMATIONAL PURPOSES ONLY.</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    23, 2025</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BY
    ORDER OF THE BOARD OF DIRECTORS</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Datuk Dr. Doris Wong Sing Ee</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong Sing Ee</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Executive Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appendix
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF THIRD AMENDMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CYCLACEL
PHARMACEUTICALS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is hereby certified that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>FIRST</U>:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    name of the Company is Cyclacel Pharmaceuticals, Inc. (the &ldquo;Corporation&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECOND</U>:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
                                            C of Article IV of the Amended and Restated Certificate of Incorporation of the Company is
                                            hereby amended and restated in its entirety to read as follows:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Effective
    as of&thinsp;[__ p.m.], New York City time, on [___] (the &ldquo;<U>Effective Time</U>&rdquo;), each [___ (__)] shares of Common
    Stock issued and outstanding or held as treasury shares immediately prior to the Effective Time (the &ldquo;<U>Old Common Stock</U>&rdquo;)
    shall automatically and without any action on the part of the holder thereof be reclassified, combined and converted into one (1)
    share of Common Stock (the &ldquo;<U>New Common Stock</U>&rdquo;) (such reclassification, combination and conversion, the &ldquo;<U>Reverse
    Stock Split</U>&rdquo;). No fractional shares shall be issued in connection with the Reverse Stock Split. Instead, holders who would
    be entitled to receive fractional shares of Common Stock because they hold a number of shares not evenly divisible by the Reverse
    Stock Split ratio shall have their fractional share (a) round up to the nearest whole number the New Common Stock issuable to any
    holder who would otherwise be entitled to receive one-half or more of a fractional New Common Stock, and (b) round down to the nearest
    whole number the securities issuable to any holder who would otherwise be entitled to receive less than one-half of a fractional
    New Common Stock. For those stockholders who hold shares with a brokerage firm, the Company will round up or down fractional shares
    at the participant level. No cash will be paid in lieu of fractional shares. Whether or not the Reverse Stock Split would result
    in fractional shares for a holder of record of Old Common Stock as of the Effective Time shall be determined on the basis of the
    total number of shares of Old Common Stock held by such holder of record as of the Effective Time. Each stock certificate that, immediately
    prior to the Effective Time, represents shares of Old Common Stock shall, from and after the Effective Time, automatically and without
    the necessity of presenting the same for exchange, represent the number of whole shares of New Common Stock into which the shares
    of Old Common Stock represented by such certificate shall have been reclassified, combined and converted in the Reverse Stock Split.
    The New Common Stock issued in the Reverse Stock Split shall have the rights, preferences and privileges as the Common Stock.&rdquo;</FONT></P></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>THIRD</U>:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amendment of the Certificate of Incorporation herein certified has been duly adopted in accordance with the provisions of Section
    242 of the General Corporation Law of the State of Delaware.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Certificate of Amendment to be signed by to be signed by its duly authorized officer this
[&#9679;] day of [&#9679;], 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CYCLACEL
    PHARMACEUTICALS, INC.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Datuk
    Dr. Doris Wong Sing Ee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>formdef14c_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdef14c_001.jpg
M_]C_X  02D9)1@ ! 0$       #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !. ,@# 2(  A$! Q$!_\0
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MKV[&@^-?$MSXLNO#(L+S7/$VGS:])=VG@T?W&1*4C12%4@<J@"JI))*J 2
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M2[V6X\0^-YM2TVX@U/1#J TK5+>"^M"EPOAWP[XZN+&:'6;+1Q+QO[2WQ_\
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MXKVB:EX/T_69?%>D>'M1M[:ZT_75N;N2YT*_>_L@+R=29G+3O^S98#:0P(
M)Z=N_H0>W&,8/>OQL_X*O<_$+_@GB>H/[8O@+UQ_R,G@<^X^@) SC) R:^<X
M%XCS/BKCGAW!9]2RC&8.G+B&O2PM/AOAK 4*4GP?Q=R4HPRW(,"I86BX4IT,
M+7EBZ%&M0P^(I*&(P]'$1^T\4.#LDX#\,^*\SX7K9_@<QK/@["5\;6XQXRS3
M$5J<O$+@/VE>4\XXJS+V>*K1KXFE7Q>&IX#$5\/BL3@ZSE@Z]3"'[,Q ", #
M&-W'I\QX],>@' ' XKYF_; ^/5E^S;^SM\6OB[=2VXO?"OA2Y7PU:W+[8[_Q
MCKSQZ%X.LF7<'DAE\17MG)?&+YH-,@O[L[8[:62/Z5CDP /E"@D'D\#)[].O
MKCT."<#\%O\ @JW\;_!&K?M!_LR?LW^,WUZ_^%_A77]-^/OQ[T_P?H=YXKUO
M4-(TN:^T_P $>%QH^F-YTB:G%!XHM-9@NGBBLK;Q;X7\0NK)9P"X^0\-^&EQ
M7Q9DV6UL-7Q.7X=5,YSJCAX<]:IDV1X7^U,PPU*,ITXNOF$<-ALHPT95*2GB
M<WIQYX\K<?T/QCXR_P!1_#S/LWH8S"X'-<9'#<.</XC&5/9X>CG_ !+B8Y+E
MN+KM0JR^K95]<QN>XR4:-1PPF15IN#32D?L _$?]HKX-?M*>'O@#^U/\4/'W
MQ F_:3_9X\"_'#X:3_$/Q!KNO77A?Q/'!K>IZ]X$LGUW5=1;3-0&EP^(TUZP
M@:R1;OPIHTRV-O#?VJ3_ *@_ME?M3>'/V0?@/XH^,>O6J:S>6/V?1/"'AOSS
M:_\ "2^,]7$ZZ/IDUV%=K/3+>*WO-9UR]2.26VT+2M3ELXKF_6TM+G\/OV_/
MVW_@]\4I?@%\;/@AHOQ8TKXQ?LW?$ZV\7:/<>+_AAJOAK0=4\&W\EE<>(M O
M]<\VZAMX)=3T70H?(NE6.73[O7;6(HU[*TGT7_P5S\7Z3\0OV6/V4_CSX<CN
MM?\ A._QE^'7Q)U%8;82R77A;Q5X+U/5-#EOK4&8)<7%K+-H36\[*D6HZE'9
M7&&=37[%F7!53B7C/PPSGB3A[_5VEQICL3E'$N1X/"X3*:#SOARIF>+A@\#2
MP,_JN$I\3Y&LBI8>5%4)2K4,RG&*Q4Y59?SID_B5'@KPX\:^'.#N+7Q=BO#W
M+L#Q!P;Q)C,?C.(,5#AWC&&1X"OC<?6S12QF.J<'<4U.)Z]:GB7B*4,-7RJC
M-K!4XTSTGX=?LK_MR?M&^']/^)7[3?[9/QE^!6K>*+6#7=-^"W[.S+\-$\#Z
M;J"K=Z?I.O:O9R+=3:K;0LD>HZ1J,.MZC8.&L=1\37U\+GR?<-0^$GQB_9F_
M9/\ VNY==_:>^*WQIOK?X._$CQ/\-O%GC::6Q\>_#R\T+X<^)IO]%\6VFHW6
MI:C>MJD=GJ=CJ22V#V$UI&;.U@<R33?H3H.M:5XBTNP\1:%J%GJVA:]IUEK6
MBZKI\J7%AJ>DZI E]I^IV=S%F.YM+^SG@NK:>,E)H9$D1BK9'A7[8S _LC?M
M0\@_\8]?&?C.,?\ %N/$@..XY]NN.<XK\MCQGG.>YQEF58O!Y%@,HJ\2Y!"&
M29?POP_@<-EM.AQ)E7+@\-562+-H>RBZF%Q3Q6:XG$8R*Q-/,?K'MZ]%?MU3
MPXX<X:X8SO/L!F?%&;9_A>#.**SXES3C?BO-,7F];$\)9Y*IF&*P\^)'D-3Z
MQ*=/&X&."R3"X3+I3P57*)8=8;"5W^5'['/[+WQ6_:1_9M^%OQI\4_M\?MR>
M'=?\=6'B2YU#1_#WQJOVT2R;0O&/B;PO"MD=5M+_ % K-:Z);W<GVS4;B5KF
M6XVR!1!&WK?_  4>F^)/[,?_  3QTG3O OQO^,-YXT\*>-O NA/\7M0\<:M:
M?%+Q!::CK>L7%T^O>+-$GTV^O)+B&6&RG02B&>TL[6"=)5CP?GC]@_\ 9&^/
M'Q*_9.^#WC/P=^W7\<?A!X>U[3?%$NF?#KPKHVF7GA[PXME\0/%VF72:;<2:
M[93R+J=Y:7.L3>;"CPW5]<AF,21B+V;_ (*U>&=9\%_\$V=(\)>(O&.K_$+7
M?#GC'X2:/J_CG7H8X=;\6W]A->P7.OZK##+<11W^I2(;FY1)YE$CMB5P-Q_6
ML15P^+\9^'LEJ<1Y%G^74O%/$89\,8?A"AE=/*<-0Q^<8>EA,3B*O"^787,L
M-AH166^PCB<PH59T5B72J4G3K+\%PU'&9?\ 1SXLXDI<)\5<,9Q7\#\)C%QG
MC>/\3G4\\QF(ROA_%UL=@<'2XTS?'Y/B\75;S:.*E@\JQ-*&(>$]M1K>UP\O
MV/\ ",LLOAKP]+-++---HFD33SS2-+//-+I]LTL\\SEGEFE?,DLKDO)(S.Y+
M,22HO!YQX6\-^V@Z-CT.--MCVR>I _EQM+%?S)5M[6LE9)5JRM:RLJ]=))62
M2222222222LE;^W,%*^#PK;;;PN&;;;DVWAL.VVVY-MMMMMMMMMMMMO\L/@]
M$?V</^"FWQ_^%MVL=AX._;&\&:?\=_AQ,T@$5Y\1/"3:FOQ!T&#Y"KZK=2W?
MC/Q9>(#^YL+?26E\XW< B]+F"_LU?MZW>NWC_8OA9^W+H>A>'SJ#?)IV@_M/
M?"RQN8_#^D7D\CBTTW_A9_PX?45THLQN]>\6^'X[%+67"O;=Y^W9^SUXN^+G
MP[\,?$'X/3P6'[2'[/7B>+XK_!&_DV*FLZQI0AFU_P"'FHEY+6*;1OB!IUI'
MID]G-<6EA>:I:Z/;ZO<QZ-/J\=P>%O$7P<_X*1_LK[+RUU+1;77PFG>)M*M;
MR32OB!\$?C#X0GAN'_L^]2.*_P! \:> /$ZVFK^'[V:VM_[4T\VCWMC-I&LW
MVE3?K%3,\-F6 R_B;%.O5R[,<AP/ASXAQPT'7Q6 QF!H4J?#/$:H2E'VCQ."
MRK(\TP=ZE..*S3A3.\G6*HXG,,.G_/\ 1R/%9+FN;\$X)8>AG.3\49EXN>$D
M\74^KX/-<!FV)Q.(XSX.>+:J>P6%S'.^),HQT5&K+!9)QCPWGWU:O@LKQ:CY
M3I'P\T/P+J_CK]B+QQ=7GAGX;?$_6]?^+/['WCG2I4M+KPSJL?B!/B-K_P -
M= N)H_L]E\1O@9\2H7^)WPYL9Y+J+Q'\/]5@L[:UN(/ OBRTKN]&UOQ</B)8
MPZK>>$_AC^UE#H]MX>\2>'==2_L?@O\ M:^#_#/VJ71_$W@;6+=;O4=)U2V2
M^O;FTFTVU\2?$+X+2ZOK7ACQOX,^)7@:'P;K^O\ ):)XLMO&]M:?L9?MU6-I
M8?%XS6MQ\+/BII\]]X0\-_M -X5E@FT+XK?!GQ?IMS;7/@3X\>%YC:WOBGP3
MIVIZ=XET#6[C^V_#"7GA+739V?:^(M%^+WA+0KCX?_'/X8V?[:'P<CGMVTSQ
MCH.B^#D^,&FPV[,-/N_B+\)_$$NB>%/%_B+2MSD?$7X2:IH>NWTBI<V/PHTJ
M]2:[N,,<JOM_89C4PM7'XJB\54MB<&\OXBIXB%#"3XFX<S',JM#)\VP^?T,%
M@O\ 6'A[,<3E&+_MS _VEEV.RKB"AC\#AHP-/#4\-'%931QM+*L!B(8.DGA,
MQ_M7A"K@Z^+S&GP;QEE>3TL9Q!D&-X3Q6:9G#A'B_*,OS_!+AO,Y9+G&!S[A
M/%Y;C,;] 67QB\=65M-;ZW^SA\7(]6M5/G)X8U7X3^)] O[@+E_^$?UR7XC:
M%>7&GN0/LMUXGT'PC?/&Z->Z5I\@DBCYW5OBMXRT<1?$;XKV7@_]G_X0Z$9_
MMVG>-]?T[Q/\3/%US>6L]IHVD./"6H7?A'P;>IJLUO=6&B^%O$'Q:\3>-[G[
M%H6G6?A^[>:'4OE5O&?[,6DQI91_&W]L7X1(@)E\&Z[/^UA97UKY[--]B%I\
M3O"?BK5]/V"3RH++P[JEG;VD0C@L%AC2(#3\*^(_A5:Z_:^)O@5^SI\?_P!H
MKXG)'.N@_$_XM67Q,TC2-!>\B>WGDM/C)^U5>QWW@_1[A))%U*Q^$.AZU=F.
M5Q'X4NS,D4OE+AZ-.G*I/*,PHTZD91E5KY;BLNHPBU:;AFO$?$:R/ .S=L53
MGG]6@I\V%H8B<:,Y>VN-<17J4,-#B7+,15I5:4J5##9QEN;UZ\X-<BJ9%P3P
M?/B[,U&<+O 8FEPE3Q4TJ.8XO!1>(P\/T>\,>(8O$^BZ9KD%AJVEP:MIUAJ<
M&GZ]IM]HFMV<&HVXN8;?6-$U.WM=1T?48D<)=Z;J$$-Y9SAK:ZBBGBD1>BY[
M_P \_P!!7R%X??QQ\,;/Q3\<_P!J+XR>%M TRS\.W$%QX/\ #LZ>&_@9\+M
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MW<L9+F8,S""OL,'B<KQ=%X;A[/,#@</B:SKRX(X\A]<RR&+JQ2E+)L_^IXC
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110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
